Anticorps Recombinant de lapin anti-Endoglin/CD105
Endoglin/CD105 Recombinant Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
FC
Conjugaison
Non conjugué
CloneNo.
241196D9
N° de cat : 98013-2-RR
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en cytométrie | CMSP humaines |
Dilution recommandée
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Informations sur le produit
98013-2-RR cible Endoglin/CD105 dans les applications de FC et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Lapin / IgG |
Clonalité | Recombinant |
Type | Anticorps |
Immunogène | Protéine recombinante |
Nom complet | endoglin |
Masse moléculaire calculée | 71 kDa |
Numéro d’acquisition GenBank | BC014271 |
Symbole du gène | CD105 |
Identification du gène (NCBI) | 2022 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Protein A purfication |
Tampon de stockage | PBS with 0.09% sodium azide |
Conditions de stockage | Store at 2 - 8°C. Stable for one year after shipment. |
Informations générales
Endoglin (ENG, CD105) is a homodimeric cell membrane glycoprotein of 180 kDa, composed of disulphide-linked subunits of 90-95 kDa. Endoglin is a proliferation-associated and hypoxia-inducible protein mainly expressed on vascular endothelial cells. It acts as an accessory receptor for transforming growth factor beta (TFG-β) and is involved in vascular development and remodeling. The important role of Endoglin in angiogenesis and in tumor progression makes it an ideal target for antiangiogenic therapy and a good marker for tumor prognosis. (PMID: 1326540; 14528280; 21737653; 12773481)
Protocole
Product Specific Protocols | |
---|---|
FC protocol for Endoglin/CD105 antibody 98013-2-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |